Prof. Jana Hercogová, MD, PhD is Chairwoman and Scientific Board Member at the Dept. Dermatology and Venereology, 2nd Medical School, Charles University Prague, since 1995 and 1999 respectively. In 2001, she became Professor of Dermatology, Venereology, Cell Biology and Psychocutaneous Medicine International Faculty of the “Centro Interuniversitario di Dermatologia Biologica e Psicosomatica”, Florence, Siena, Milan, Italy. Since 2012, Dr. Jana Hercogová is Chairwoman Dermatology Dept, Institute of Experimental Medicine, Prague.

Dr. Hercogová has extensive clinical trial experience in onychomycosis, acne vulgaris, dermatitis atopica, psoriasis vulgaris, chronic urticarial, herpes labialis, and wound healing. She has a large library of published research and lectures, including seven books, 30 chapters, 178 journal articles, and 235 invited lectures.

Currently, Prof. Hercogová is the President of the European Academy of Dermatology and Venereology (2012-2014); Vice-President of the Czech Laser Society (since 2008), Secretary-General of the Czech Academy of Dermatology and Venereology (since 2012); Vice President of the European Society for Cosmetic and Aesthetic Dermatology (since 2010); President Elect of the European Academy of Dermatology and Venereology (2010-2012); Executive Committee Member, Communication Committee Chair, of the International Society of Dermatology (since 2009); International Fellowship Mentor International Society of Dermatology (since 2009); International Committee Member Women´s Dermatologic Society (since 2009), and International CommitteeDonne Dermatologhe Italia (since 2005).

Prof. Jana Hercogová’s teaching extends to Visiting Professor, University of Siena, Italy (since 2003) and Professor honoris causa, China University, 1st Medical Hospital, Shenyang, China (since 2011). She currently serves as an editorial board member for Medicína po promoci (Czech), since 2004; Dermatologia kliniczna (Polish), since 2005; Remedia (Czech), since 2006; Acta Dermo-Sifiliográficas, since 2007; Brazilian Annals of Dermatology, since 2009; Journal of Clinical Dermatology, since 2009; Acta Dermatovenerologica Albanica, since 2009; Dermatologie pro praxi (Czech), 2010-2011; Indian Dermatology Online Journal, since 2012; and Dermatologí a Cosmética, Médic a y Quirúrgica” (Mexico), since 2013 to list a few.

Dr. Hercogová graduated from Charles University Prague, 2nd Medical School with a MUDr., Medical School Qualification degree with honours; 2nd Medical School, Charles University Prague (Czech equivalent to M.D.); Specialist on Dermatology and Venereology 1st degree, 2nd degree; and Institute for Postgraduate Education, Prague (Czech equivalent to Certification of the American Board of Dermatology).

Dr. Lonky received is MD degree from SUNY Stony Brook in 1982, completed his residency in OB/GYN at Harbor UCLA Medical Center in 1986. He then joined the the Southern California (Kaiser) Permanente Medical Group (SCPMG). He received an MPH in Health Policy and Management from UCLA in 1997. He served as an elected member of the SCPMG Board of Directors for 15 years beginning in 2002 while continuing to actively practice, teach, and conduct research.

He is a Clinical Professor of Obstetrics and Gynecology at the University of California Irvine School of Medicine. His expertise has been evident in the field of cancer screening, health policy driving value based care, and the prevention of lower genital tract malignancy. He has traveled worldwide teaching and volunteering clinical services regarding cancer prevention, diagnosis, and treatment in underserved areas around the world. He was the recipient of the lifetime achievement award from the Jonathan Fielding UCLA School of Public Health, and Meritorious Achievement Award from the American Society of Colposcopy and Cervical Pathology. He has also been a volunteer and director supporting Mental Health Services in the US through the National Alliance on Mental Illness (NAMI).

Dr. Lonky is involved the transformation of the Kaiser Permanente EMR as a robust clinical practice management and research technology. He has received many awards related to community service, clinical excellence, and research from Kaiser Permanente.

Dr. Lonky is an entrepreneur multi-patented inventor, and pioneer in the development of several surgical tools and devices used today, worldwide. He is the Founder and CEO of Histologics LLC based in Anaheim California.

Dr. Shapiro is one of the most experienced hair dermatologists in the world and has specialized in hair disorders for the past 25 years. He is the first dermatologist in the world to exclusively restrict his practice to both medical hair and scalp disorders as well as hair transplant surgery. He holds dual academic appointments at the New York University Langone Medical Center and the University of British Columbia. He is also the Director of the Hair Transplant Centre (www.htvancouver.com) in Vancouver at the University of British Columbia.

Professor Shapiro's three main professional goals have always been, since the start of his career, patient care, research and education. Dr. Shapiro is the founder of the first comprehensive integrated medical and surgical hair clinic in the world. His hair clinics are one of the busiest, if not the busiest, in the world. He has trained over thirty international hair fellows from four continents. Prof. Shapiro received his medical degree from McGill University and did his residency training at the University of British Columbia. He established the University of British Columbia Hair Research and Treatment Center in 1986. His major interests include basic science hair biology, alopecia areata, cicatricial alopecia,androgenetic alopecia, telogen effluvium, and all other forms of hair loss as well as hypertrichosis/hirsutism (too much hair in women) and primary scalp skin disorders. He has published over 100 peer-reviewed papers including a review in the New England Journal of Medicine, 15 book chapters, and two books. He has lectured internationally on hair-related topics on 173 occasions on 6 continents. Patients come from all continents to consult with him in New York and Vancouver.

Prof. Shapiro has served as reviewer for the Journal of European Academy of Dermato-venereology, Journal of Investigative Dermatology, Journal of the American Academy of Dermatology, Pediatric Dermatology, Dermatologic Surgery, British Journal of Dermatology, and Archives of Dermatology. He has served on the Editorial board for the Journal of the American Academy of Dermatology. He is an active member of the American Academy of Dermatology, American Dermatological Association, European Academy of Dermatology and Venereology, American Society for Dermatologic Surgery, North American Hair Research Society, European Hair Research Society, International Society of Hair Restoration Surgery, and Canadian Dermatology Association. In 1998-2004, he served as Secretary-Treasurer of the North American Hair Research Society, and then from 2004-2007, he served as its President. In 2007, he was the President of the largest scientific global hair conference, the International Congress of Hair Research, which took place in Vancouver. He will be the President of the next largest global dermatologic meeting, the World Congress of Dermatology, which will take place in Vancouver in 2015. It is predicted that this will be the largest dermatologic meeting ever to take place.

Prof. Shapiro has spoken at every American Academy of Dermatology meeting for the past twenty years. He has chaired symposia at the American Academy of Dermatology, European Academy of Dermatology and Venereology, World Congresses of Hair, and previous World Congresses of Dermatology. He has also served on the Education Committee of the AAD and Canadian Dermatology Association. He is also president of the Canadian Hair Research Foundation (www.hairinfo.org).

He serves on the Scientific Commitees of the National Alopecia Areata Foundation (www.naaf.org) and Cicatricial Alopecia Research Foundation (www.carfintl.org).

He is a sought after speaker and has appeared in national and international radio and television. He has been quoted in the media such as USA Today, ABC News, Men's Health, Oprah Magazine and Scientific American.

Prof. Carlos Wambier, MD, PhD is recognized worldwide as an expert in the field of cosmetic procedural dermatology, with expertise in injectables (fillers, neurotoxins, and lipolysis), lasers (Q-switched nano and picosecond laser for tattoo removal and pigmentary disorders), and drug-delivery procedures for both medical and cosmetic indications (vitiligo, scars, idiopathic guttate hypomelanosis, and hair growth). Dr Wambier is internationally acclaimed as a leader in chemical peels, with numerous publications on the subject including the cover of the Journal of the American Academy of Dermatology of August 2019, which featured two CME articles about chemical peels which he was the leading author. His innovations in techniques and research in the field of chemical peels have triggered a renewed interest on phenol-croton oil peels (also known as advanced, or deep peels) in the dermatologic academia.

Prof. Wambier credentials include medical degree (2004), medical specialty in dermatology (2009), and Science Doctor degree (ScD/PhD, 2012) all from the University of Sao Paulo, the most prestigious university of Latin America and the Southern Hemisphere. He became an expert in hair growth, wound healing, inflammation, drug eruptions, photodynamic therapy, and leprosy during his years involved in research at Ribeirão Preto Medical School. After that period, he dedicated his efforts for Chemical Peeling when he became Associate Professor of Dermatology at the State University of Ponta Grossa.

In hair research, Prof. Wambier has pioneered the use of injectable dutasteride, finasteride, and minoxidil in Brazil, which he terms intralesional therapy, to oppose banalized “mesotherapy” due to the difference in technique and the use of specific medications. He is constantly invited for national and regional meetings to give lectures on the subject, and has defended the use of injectables as an adjuvant booster to usual oral and topical therapy. His rationale has triggered numerous adepts, and instigated clinical trials in Brazil. Over the past 6 years, he also adopted drug-delivery through tattoo machines as a standard procedure for androgenetic alopecia hair restoration, which combines dermal delivery with microneedling. He presented a series of cases in the World Congress of Hair Research, in Barcelona, 2019.

Prof. Wambier has given over 50 lectures in national and international dermatology meetings, and over 100 regional lectures. Has been a chair of the main academic meetings of dermatology worldwide, including the World Congress of Dermatology, in Milan, 2019, he was chair of Basic Cosmetic Dermatology session, and the World Congress of Cosmetic Dermatology, in Lima, 2019, he was chair of the Pigmentary Lesions session. Many other organization/lectures in the CILAD, RADLA, AAD, ASDS, SBD. Dr Wambier has been selected as one of the few oral examiners for the Brazilian Board of Dermatology during a period it was implemented (2015-2016). Has served as an Ad hoc consultant for funding agencies, such as WHO and Araucaria Foundation.

In 2019 Dr Wambier was involved in multiple clinical trials about the use of novel JAK inhibitors for the treatment of severe Alopecia Areata, during his post-doctorate sabbatical year at Yale University (after 10 years as a professor in Brazil), during that period, he developed a new method for evaluating the Severity of Alopecia Tool (SALT) score, with the use of the thumb as a precise measurement of 1% of the scalp surface area.

Since 2020 Prof. Wambier is the Director of Cosmetic Research at Brown University, RI, USA, and is involved in innovative research.